Pure erythroid leukemia is characterized by biallelic <i>TP53</i> inactivation and abnormal p53 expression patterns in <i>de novo</i> and secondary cases

• Hong Fang,
• Sa A. Wang,
• Joseph D. Khoury,
• Siba El Hussein,
• Do Hwan Kim,
• Mehrnoosh Tashakori,
• Zhenya Tang,
• Shaoying Li,
• Zhihong Hu,
• Fatima Zahra Jelloul,
• Keyur P. Patel,
• Timothy J. McDonnell,
• Tapan Kadia,
• L. Jeffrey Medeiros,
• Wei Wang

Affiliations

Hong Fang

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston

Sa A. Wang

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston

Joseph D. Khoury

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston

Siba El Hussein

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston

Do Hwan Kim

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston

Mehrnoosh Tashakori

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston

Zhenya Tang

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston

Shaoying Li

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston

Zhihong Hu

Department of Pathology, The University of Texas Health Science Center at Houston

Fatima Zahra Jelloul

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston

Keyur P. Patel

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston

Timothy J. McDonnell

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston

Tapan Kadia

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston

L. Jeffrey Medeiros

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston

Wei Wang

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston